Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Jupiter Wellness Inc (NQ: JUPW )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 14, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Jupiter Wellness Inc

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
TLRY is Making waves with this NASDAQ; JW-300 Demonstrates Efficacy in Treatment of Developing Burns (sunburn) in a Double-Blinded Placebo Controlled Clinical Trial (NASDAQ: JUPW) Jupiter Wellness
Via Get News
Jupiter Wellness Announces JW-300 Clinical Trial Results
JW-300 Demonstrates Efficacy in Treatment of Developing Burns (sunburn) in a Double-Blinded Placebo Controlled Clinical Trial. JUPITER, FL / ACCESSWIRE / November 16, 2021 / Jupiter Wellness, Inc.... 
From Jupiter Wellness, Inc.
Via AccessWire
NASDAQ Company Completes Pre-IND meeting with the U.S. Food & Drug Administration for JW-100 in the Treatment of Eczema (NASDAQ: JUPW) Jupiter Wellness
Via Get News
Jupiter Wellness Completes Pre-IND meeting with the U.S. Food & Drug Administration for JW-100 in the Treatment of Eczema
JUPITER, FL / ACCESSWIRE / November 11, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a clinical stage company developing cannabinoid receptor agonists for the treatment of eczema, actinic keratosis,... 
From Jupiter Wellness, Inc.
Via AccessWire
Exposures Product Safety
Big update for NASDAQ Biotech Jupiter Wellness: NASDAQ: JUPW Applies for IND number from the US Food & Drug Administration
Via Viz Release
Exposures Product Safety
NASDAQ Company Completes Pre-IND meeting with the U.S. Food and Drug Administration for JW-100 in the Treatment of Eczema (NASDAQ: JUPW) Jupiter Wellness
Via Viz Release
SPAC Targeting AI Medical Therapeutics and Diagnostics; (NASDAQ: JUPW) Jupiter Wellness Sponsors Jupiter Wellness Acquisition
Via Get News
Topics Artificial Intelligence
Exposures Artificial Intelligence
Jupiter Wellness Sponsors Jupiter Wellness Acquisition Corp SPAC Targeting AI Medical Therapeutics and Diagnostics
AI in medicine is projected to grow 18X from 2018 through 2025 to $35 billion JUPITER, FL / ACCESSWIRE / November 3, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced that it has filed a... 
From Jupiter Wellness, Inc.
Via AccessWire
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
SPAC Targeting AI Medical Therapeutics and Diagnostics; (NASDAQ: JUPW) Jupiter Wellness Sponsors Jupiter Wellness Acquisition. AI in medicine is projected to grow 18X from 2018 through 2025 to $35 billion
Via Viz Release
Topics Artificial Intelligence
Exposures Artificial Intelligence
NASDAQ Company Announces 1st Patient Dosing for Placebo Controlled Trial of JW-300. Treatment of First Degree Burns: Jupiter Wellness, Inc. (NASDAQ: JUPW)
Via Get News
Exposures Product Safety
Jupiter Wellness Announces First Patient Dosing for Double-Blinded Placebo Controlled Trial of JW-300 for the Treatment of First Degree Burns
JUPITER, FL / ACCESSWIRE / October 19, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a clinical stage company developing a cannabinoid receptor agonist for the treatment of first degree burns, announced... 
From Jupiter Wellness, Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
NASDAQ Company Announces 1st Patient Dosing for Placebo Controlled Trial of JW-300. Treatment of First Degree Burns: Jupiter Wellness, Inc. (NASDAQ: JUPW)
Via Viz Release
4 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider... 
Via Benzinga
NASDAQ Company in the Multi-Billion Dollar Market Treating Skin Disorders Including Skin Cancer: Jupiter Wellness, Inc. (NASDAQ: JUPW)
Via Get News
Jupiter Wellness Provides Shareholder Update on Multiple Clinical & Commercial Milestones
JUPITER, FL / ACCESSWIRE / October 7, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today provided an update on its advancing clinical programs and commercial progress. Commercial: Photocil™ to Launch... 
From Jupiter Wellness, Inc.
Via AccessWire
Exposures Product Safety
Jupiter Wellness Announces Multi-Year Extension of Endorsement Agreement with Pro Golfer Ernie Els
Pro Golf Hall of Fame Legend Extends Endorsement of CaniSun Suncare Products JUPITER, FL / ACCESSWIRE / September 8, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a developer of enhanced skin care... 
From Jupiter Wellness, Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
Biotech Requests Pre-IND Meeting with the US FDA: Jupiter Wellness: NASDAQ: JUPW JW-100 Clinical Program Treatment for Mild to Moderate Eczema
Via Get News
Exposures Product Safety
Jupiter Wellness Submitted a Pre-IND Meeting Request with the US FDA for its Proposed Clinical Program of JW-100 as a Treatment for Mild to Moderate Eczema
Following receipt of a Pre-Assignment number from the FDA Jupiter Wellness requests Pre-IND meeting JUPITER, FL / ACCESSWIRE / August 23, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a developer of... 
From Jupiter Wellness, Inc.
Via AccessWire
Exposures Product Safety
Biotech Requests Pre-IND Meeting with the US FDA: Jupiter Wellness: NASDAQ: JUPW JW-100 Clinical Program Treatment for Mild to Moderate Eczema
Via Viz Release
Exposures Product Safety
Big update for NASDAQ Biotech Jupiter Wellness: NASDAQ: JUPW Applies for IND number from the US Food & Drug Administration
Via Get News
Stocks That Hit 52-Week Lows On Monday
On Monday morning, 207 companies hit new 52-week lows. Intriguing Points: The largest company in terms of market cap to set a new 52-week low was Koninklijke Philips (NYSE... 
Via Benzinga
Jupiter Wellness Applies for IND number from the US Food and Drug Administration
Following positive results from the JW-100 investigator initiated trials for Eczema, Jupiter Wellness to commence US FDA program JUPITER, FL / ACCESSWIRE / August 16, 2021 / Jupiter Wellness, Inc.... 
From Jupiter Wellness, Inc.
Via AccessWire
Exposures Product Safety
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday morning, 69 companies achieved new lows for the year. Intriguing Points: Las Vegas Sands (NYSE:LVS) was the largest firm by market cap to set a new 52-... 
Via Benzinga
Aegis Capital Corp. acted as Sole Bookrunner on a $32.5 Million Follow-On Offering of Common Stock and Warrants for Jupiter Wellness, Inc. (NASDAQ:JUPW).
NEW YORK, NY / ACCESSWIRE / July 26, 2021 / Aegis Capital Corp. acted as Sole Bookrunner on a $32.5 Million Follow-On Offering of Common Stock and Warrants for Jupiter Wellness, Inc. (NASDAQ:JUPW).... 
From Aegis Capital Corp.
Via AccessWire
Topics Retirement
Exposures Pension
Jupiter Wellness Closes $32.5 Million Underwritten Public Offering of Common Stock and Warrants
JUPITER, FL / ACCESSWIRE / July 26, 2021 / Jupiter Wellness, Inc. (the "Company") (NASDAQ:JUPW), today announced the closing of an underwritten public offering (the "Offering") of 11,066,258 shares... 
From Jupiter Wellness, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Mid-Afternoon Market Update: Dow Rises Over 50 Points; ImmunoPrecise Antibodies Shares Spike Higher
Toward the end of trading Thursday, the Dow traded up 0.16% to 34,853.89 while the NASDAQ rose 0.38% to 14,687.85. The S&P also rose, gaining 0.20% to 4,367.55. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
61 Biggest Movers From Yesterday
Gainers ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) shares jumped 138.2% to close at $13.22 on Thursday after the company announced new results from its TATX-03 PolyTope Therapy... 
Via Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
Gainers ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) shares climbed 129.7% to $12.75 after the company announced new results from its TATX-03 PolyTope Therapy, demonstrating... 
Via Benzinga
Mid-Day Market Update: Crude Oil Up 1.5%; Seres Therapeutics Shares Plunge
Midway through trading Thursday, the Dow traded down 0.08% to 34,768.64 while the NASDAQ rose 0.10% to 14,646.39. The S&P also fell, dropping 0.02% to 4,357.70. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Mid-Morning Market Update: Markets Mostly Lower; AT&T Beats Q2 Estimates
Following the market opening Thursday, the Dow traded down 0.24% to 34,715.42 while the NASDAQ rose 0.13% to 14,651.19. The S&P also fell, dropping 0.08% to 4,355.29. The U.S... 
Via Benzinga
Topics Stocks
Exposures US Equities
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.